Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation

International Journal of Molecular Sciences

William Peverill¹  Lawrie W. Powell¹ 

[1] Department of Gastroenterology and Hepatology, Royal Brisbane and Women’s Hospital, Brisbane 4029, Australia; E-Mails:

关键词: non-alcoholic fatty liver disease;    non-alcoholic steatohepatitis;    pathogenesis;    fibrosis;    lipotoxicity;    inflammation;    immune response;    treatment;   

DOI  :  10.3390/ijms15058591

来源: mdpi

【 摘 要 】

Non-alcoholic steatohepatitis (NASH) is characterised by hepatic steatosis and inflammation and, in some patients, progressive fibrosis leading to cirrhosis. An understanding of the pathogenesis of NASH is still evolving but current evidence suggests multiple metabolic factors critically disrupt homeostasis and induce an inflammatory cascade and ensuing fibrosis. The mechanisms underlying these changes and the complex inter-cellular interactions that mediate fibrogenesis are yet to be fully elucidated. Lipotoxicity, in the setting of excess free fatty acids, obesity, and insulin resistance, appears to be the central driver of cellular injury via oxidative stress. Hepatocyte apoptosis and/or senescence contribute to activation of the inflammasome via a variety of intra- and inter-cellular signalling mechanisms leading to fibrosis. Current evidence suggests that periportal components, including the ductular reaction and expansion of the hepatic progenitor cell compartment, may be involved and that the Th17 response may mediate disease progression. This review aims to provide an overview of the pathogenesis of NASH and summarises the evidence pertaining to key mechanisms implicated in the transition from steatosis and inflammation to fibrosis. Currently there are limited treatments for NASH although an increasing understanding of its pathogenesis will likely improve the development and use of interventions in the future.

【 授权许可】

CC BY   
© 2014 by the authors; licensee MDPI, Basel, Switzerland